Dianthus Therapeutics DNTH
NASDAQ DNTH
$85.01 -4.29 (-4.81%)
As of: Nov 12, 2026 · 10:16 AM EST

Dianthus Therapeutics (DNTH) Cost of Revenue (2024 - 2025)

Updated

Analysis

Dianthus Therapeutics (DNTH) Cost of Revenue (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 3.93 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.10 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 4.29 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.89 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 2.95 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 2.79 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.57 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.03 Bn
10 Dianthus Therapeutics 5.00 Bn 4.95 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 284,000.00
Sep 30, 2025 396,000.00
Jun 30, 2025 193,000.00
Mar 31, 2025 1.16 Mn
Dec 31, 2024 1.00 Mn
Sep 30, 2024 2.17 Mn
Jun 30, 2024 1.86 Mn
Mar 31, 2024 874,000.00
API Access

Dianthus Therapeutics Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=DNTH&period=max&api_key=YOUR_API_KEY